A review of the economics of adult congenital heart disease

Michael D. Seckeler, Ian D. Thomas, Jennifer Andrews, Keith Joiner, Scott E. Klewer

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.

Original languageEnglish (US)
Pages (from-to)85-96
Number of pages12
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number1
StatePublished - Jan 2 2016


  • Adult congenital heart disease
  • Hypoplastic left heart syndrome
  • atrial septal defects
  • chronic disease
  • economics
  • healthcare resource utilization
  • tetralogy of Fallot

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)


Dive into the research topics of 'A review of the economics of adult congenital heart disease'. Together they form a unique fingerprint.

Cite this